Significant Ownership of NOVO NORDISK A S

Signature - Title
/s/ Karsten Munk Knudsen - Karsten Munk Knudsen, Chief Financial Officer
Location
Bagsvaerd Denmark, Denmark
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by NOVO NORDISK A S.

Notify me when NOVO NORDISK A S files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of NOVO NORDISK A S

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) 7.8% 7,333,778 -18% Novo Nordisk A/S 31 Dec 2025

Schedules 13D/G Reported by NOVO NORDISK A S:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.